BRPI0817837A2 - Moduladores de gama-secretase ligados a amida - Google Patents
Moduladores de gama-secretase ligados a amidaInfo
- Publication number
- BRPI0817837A2 BRPI0817837A2 BRPI0817837-2A BRPI0817837A BRPI0817837A2 BR PI0817837 A2 BRPI0817837 A2 BR PI0817837A2 BR PI0817837 A BRPI0817837 A BR PI0817837A BR PI0817837 A2 BRPI0817837 A2 BR PI0817837A2
- Authority
- BR
- Brazil
- Prior art keywords
- amide
- secretase modulators
- related gamma
- gamma
- secretase
- Prior art date
Links
- VHNYOQKVZQVBLC-RTCGXNAVSA-N (4r,7e,9as)-7-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]-4-(3,4,5-trifluorophenyl)-1,3,4,8,9,9a-hexahydropyrido[2,1-c][1,4]oxazin-6-one Chemical compound C1([C@@H]2COC[C@@H]3CC\C(C(N32)=O)=C/C=2C=C(C(=CC=2)N2C=C(C)N=C2)OC)=CC(F)=C(F)C(F)=C1 VHNYOQKVZQVBLC-RTCGXNAVSA-N 0.000 title 1
- 229940124648 γ-Secretase Modulator Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98129307P | 2007-10-19 | 2007-10-19 | |
| PCT/US2008/080270 WO2009052350A1 (en) | 2007-10-19 | 2008-10-17 | Amine linked modulators of y-secretase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0817837A2 true BRPI0817837A2 (pt) | 2015-04-07 |
Family
ID=40090406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0817837-2A BRPI0817837A2 (pt) | 2007-10-19 | 2008-10-17 | Moduladores de gama-secretase ligados a amida |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8247610B2 (pt) |
| EP (1) | EP2212277B1 (pt) |
| JP (1) | JP5543354B2 (pt) |
| KR (1) | KR20100082351A (pt) |
| CN (1) | CN101903335A (pt) |
| AU (1) | AU2008312371B2 (pt) |
| BR (1) | BRPI0817837A2 (pt) |
| CA (1) | CA2703636A1 (pt) |
| CO (1) | CO6270315A2 (pt) |
| CR (1) | CR11450A (pt) |
| EA (1) | EA018862B1 (pt) |
| IL (1) | IL205041A (pt) |
| MX (1) | MX2010004318A (pt) |
| NI (1) | NI201000066A (pt) |
| WO (1) | WO2009052350A1 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2215043B1 (en) * | 2007-10-19 | 2013-03-06 | Janssen Pharmaceutica, N.V. | Carbon linked modulators of y-secretase |
| EA017119B1 (ru) * | 2007-10-19 | 2012-09-28 | Янссен Фармацевтика, Н.В. | МОДУЛЯТОРЫ АКТИВНОСТИ γ-СЕКРЕТАЗЫ ИЗ ГРУППЫ ПИПЕРИДИНИЛА И ПИПЕРАЗИНИЛА |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE790287A (fr) * | 1971-10-28 | 1973-04-19 | Delalande Sa | Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique |
| BE826017R (fr) * | 1974-03-19 | 1975-08-26 | Acides pyrimidin-6yl acethydroxamiques, leur procede de preparation et leur application en therapeutique | |
| US4252951A (en) * | 1979-10-09 | 1981-02-24 | Eli Lilly And Company | Isolation of syn-7-(2-amino-4-thiazolyl)-(methoxyimino)acetamido-3-acetoxymethyl-3-cephem-4-carboxylic acid |
| US5391817A (en) * | 1993-12-21 | 1995-02-21 | Bristol-Myers Squibb | Biaryl phospholipase A2 inhibitors |
| US5877399A (en) * | 1994-01-27 | 1999-03-02 | Johns Hopkins University | Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease |
| CA2406383A1 (en) * | 2000-04-13 | 2001-10-25 | Mayo Foundation For Medical Education And Research | A.beta.42 lowering agents |
| DE10131899A1 (de) | 2001-07-04 | 2003-02-27 | Boehringer Ingelheim Pharma | In vitro-Screening-Assay für gamma-Secretase |
| US20080313061A1 (en) | 2004-06-30 | 2008-12-18 | Paysetter Pte Ltd | System and Method for Facilitating Transfer of Physical Money and/or Credit |
| DE102004033876B4 (de) | 2004-07-13 | 2009-01-15 | Christoph Kaesbohrer | Dreidimensionales Struktursystem |
| GB0416508D0 (en) | 2004-07-23 | 2004-08-25 | Merck Sharp & Dohme | Therapeutic agents |
| EP1650183A1 (en) * | 2004-10-21 | 2006-04-26 | Cellzome Ag | (Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy |
| US8110681B2 (en) * | 2006-03-17 | 2012-02-07 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Compounds for the treatment of spinal muscular atrophy and other uses |
| ATE445586T1 (de) | 2006-04-21 | 2009-10-15 | Cellzome Ltd | Terphenylderivate zur alzheimerbehandlung |
| PT1849762E (pt) * | 2006-04-21 | 2009-09-16 | Cellzome Ltd | Ácidos bifenilcarboxílicos substituídos e seus derivados |
| CN101490024A (zh) * | 2006-06-09 | 2009-07-22 | Icos股份有限公司 | 用作dp-2拮抗剂的取代的苯乙酸 |
| MX2008015638A (es) | 2006-06-09 | 2009-01-09 | Icos Corp | Acidos fenil aceticos sustituidos como antagonistas de dp-2. |
| CN101861297B (zh) * | 2007-10-17 | 2014-04-23 | 詹森药业有限公司 | 联苯羧酸及其衍生物 |
| EP2215043B1 (en) | 2007-10-19 | 2013-03-06 | Janssen Pharmaceutica, N.V. | Carbon linked modulators of y-secretase |
| EA017119B1 (ru) | 2007-10-19 | 2012-09-28 | Янссен Фармацевтика, Н.В. | МОДУЛЯТОРЫ АКТИВНОСТИ γ-СЕКРЕТАЗЫ ИЗ ГРУППЫ ПИПЕРИДИНИЛА И ПИПЕРАЗИНИЛА |
| JP2011500720A (ja) * | 2007-10-19 | 2011-01-06 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｇｓｍ中間体 |
| AU2008312653B2 (en) * | 2007-10-19 | 2013-03-07 | Janssen Pharmaceutica, N.V. | Amide linked modulators of y-secretase |
| US7968725B2 (en) * | 2008-07-22 | 2011-06-28 | Janssen Pharmaceutica N.V. | Pyridinyl modulators of γ-secretase |
-
2008
- 2008-10-17 JP JP2010530134A patent/JP5543354B2/ja not_active Expired - Fee Related
- 2008-10-17 US US12/253,444 patent/US8247610B2/en not_active Expired - Fee Related
- 2008-10-17 CA CA2703636A patent/CA2703636A1/en not_active Abandoned
- 2008-10-17 WO PCT/US2008/080270 patent/WO2009052350A1/en active Application Filing
- 2008-10-17 MX MX2010004318A patent/MX2010004318A/es active IP Right Grant
- 2008-10-17 KR KR1020107010872A patent/KR20100082351A/ko active IP Right Grant
- 2008-10-17 AU AU2008312371A patent/AU2008312371B2/en not_active Ceased
- 2008-10-17 CN CN2008801215605A patent/CN101903335A/zh active Pending
- 2008-10-17 BR BRPI0817837-2A patent/BRPI0817837A2/pt not_active IP Right Cessation
- 2008-10-17 EA EA201070498A patent/EA018862B1/ru not_active IP Right Cessation
- 2008-10-17 EP EP08839840.9A patent/EP2212277B1/en active Active
-
2010
- 2010-04-13 IL IL205041A patent/IL205041A/en not_active IP Right Cessation
- 2010-04-16 NI NI201000066A patent/NI201000066A/es unknown
- 2010-04-30 CO CO10051584A patent/CO6270315A2/es not_active Application Discontinuation
- 2010-05-19 CR CR11450A patent/CR11450A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL205041A (en) | 2015-01-29 |
| EA201070498A1 (ru) | 2010-10-29 |
| IL205041A0 (en) | 2010-11-30 |
| CO6270315A2 (es) | 2011-04-20 |
| US8247610B2 (en) | 2012-08-21 |
| CN101903335A (zh) | 2010-12-01 |
| JP5543354B2 (ja) | 2014-07-09 |
| EP2212277B1 (en) | 2016-08-31 |
| WO2009052350A1 (en) | 2009-04-23 |
| NI201000066A (es) | 2010-09-13 |
| EP2212277A1 (en) | 2010-08-04 |
| CR11450A (es) | 2011-01-14 |
| AU2008312371A1 (en) | 2009-04-23 |
| KR20100082351A (ko) | 2010-07-16 |
| MX2010004318A (es) | 2010-04-30 |
| AU2008312371B2 (en) | 2013-06-20 |
| US20090105300A1 (en) | 2009-04-23 |
| CA2703636A1 (en) | 2009-04-23 |
| JP2011500722A (ja) | 2011-01-06 |
| EA018862B1 (ru) | 2013-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2020034I1 (el) | Κεφαλοσπορινη που διαθετει ομαδα κατεχολης | |
| BRPI0813653A2 (pt) | Compostos de imidazotiazol moduladores de sirtuína | |
| BRPI0813651A2 (pt) | Compostos de tiazolopiridina moduladores de sirtuína | |
| BRPI0917394A2 (pt) | moduladores de mif | |
| BRPI1014636A2 (pt) | moduladores de gpr 119 | |
| IT1393131B1 (it) | Controvento a ingobbamento limitato | |
| DK2038356T3 (da) | Væskehærdning | |
| BRPI0818253A2 (pt) | Moduladores de gpr40 bifenil substituídos | |
| PL1976509T3 (pl) | Modulatory PPAR | |
| DE502008000524D1 (de) | Flüssigkeitsverdampfer | |
| FR2934802B1 (fr) | Pistolet a attaches | |
| DK2297100T3 (da) | Tetrahydrocyclopenta[b]indol-androgenreceptor-modulatorer | |
| CU23870B1 (es) | Derivados de ciclopropilamida como moduladores h3 | |
| DE602008003191D1 (de) | Tintenkartuschen | |
| BRPI0813230A2 (pt) | Moduladores de calicreína 7 | |
| DK2435410T3 (da) | LXR-modulatorer | |
| DK2512451T3 (da) | Modulator | |
| UA19086S (uk) | Чорнильний картридж | |
| BRPI0817149A2 (pt) | Cartucho de tinta | |
| BRPI0911634A2 (pt) | processo para a preparação de 5-(2-amino-pirimidin-4-il)-2-aril-1h-pirrol-3-carboxamidas | |
| BRPI0810195A2 (pt) | Moduladores de gpbar1 | |
| BRPI0816512A2 (pt) | Cartucho de tinta | |
| NO20071562L (no) | Beleggingssammensetning | |
| BRPI0816154A2 (pt) | Moduladores canabinóides de 5-vinilfenil-1-fenil-pirazol substituídos | |
| DK2271634T3 (da) | Modulatorer af dopamin-neurotransmission |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |